BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21516817)

  • 21. The human papillomavirus E7 protein shines a spotlight on the pRB family member, p130.
    Roman A
    Cell Cycle; 2006 Mar; 5(6):567-8. PubMed ID: 16582614
    [No Abstract]   [Full Text] [Related]  

  • 22. Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130.
    Mayol X; Garriga J; Graña X
    Oncogene; 1995 Aug; 11(4):801-8. PubMed ID: 7651744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pRb-related protein p130 is a possible effector of transforming growth factor beta 1 induced cell cycle arrest in keratinocytes.
    Herzinger T; Wolf DA; Eick D; Kind P
    Oncogene; 1995 Jun; 10(11):2079-84. PubMed ID: 7784052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
    Fischer M; Quaas M; Nickel A; Engeland K
    Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
    Hu X; Cress WD; Zhong Q; Zuckerman KS
    Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes.
    Robles SJ; Shiyanov P; Aristodemo GT; Raychaudhuri P; Adami GR
    DNA Cell Biol; 1998 Jan; 17(1):9-18. PubMed ID: 9468218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. pRb2/p130 and p107 control cell growth by multiple strategies and in association with different compartments within the nucleus.
    Zini N; Trimarchi C; Claudio PP; Stiegler P; Marinelli F; Maltarello MC; La Sala D; De Falco G; Russo G; Ammirati G; Maraldi NM; Giordano A; Cinti C
    J Cell Physiol; 2001 Oct; 189(1):34-44. PubMed ID: 11573202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HPV 16E7 and 48E7 proteins use different mechanisms to target p130 to overcome cell cycle block.
    Nor Rashid N; Yong ZL; Yusof R; Watson RJ
    Virol J; 2016 Jan; 13():2. PubMed ID: 26728921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of alterations of Rb2/p130 tumor suppressor in all-trans-retinoic acid resistant SK-OV3 ovarian carcinoma cells.
    Fields AL; Soprano DR; Soprano KJ
    J Cell Physiol; 2008 Oct; 217(1):77-85. PubMed ID: 18446820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TGFbeta-mediated formation of pRb-E2F complexes in human myeloid leukemia cells.
    Hu XT
    Biochem Biophys Res Commun; 2008 May; 369(2):277-80. PubMed ID: 18294958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RB and RB2/p130 genes demonstrate both specific and overlapping functions during the early steps of in vitro neural differentiation of marrow stromal stem cells.
    Jori FP; Melone MA; Napolitano MA; Cipollaro M; Cascino A; Giordano A; Galderisi U
    Cell Death Differ; 2005 Jan; 12(1):65-77. PubMed ID: 15459751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neural differentiation of brain-derived neurotrophic factor-expressing human umbilical cord blood-derived mesenchymal stem cells in culture via TrkB-mediated ERK and β-catenin phosphorylation and following transplantation into the developing brain.
    Lim JY; Park SI; Kim SM; Jun JA; Oh JH; Ryu CH; Jeong CH; Park SH; Park SA; Oh W; Chang JW; Jeun SS
    Cell Transplant; 2011; 20(11-12):1855-66. PubMed ID: 21375801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
    Kiess M; Gill RM; Hamel PA
    Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A decline in Wnt3a signaling is necessary for mesenchymal stem cells to proceed to replicative senescence.
    Jeoung JY; Nam HY; Kwak J; Jin HJ; Lee HJ; Lee BW; Baek JH; Eom JS; Chang EJ; Shin DM; Choi SJ; Kim SW
    Stem Cells Dev; 2015 Apr; 24(8):973-82. PubMed ID: 25437011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-apoptotic function of the E2F transcription factor 4 (E2F4)/p130, a member of retinoblastoma gene family in cardiac myocytes.
    Dingar D; Konecny F; Zou J; Sun X; von Harsdorf R
    J Mol Cell Cardiol; 2012 Dec; 53(6):820-8. PubMed ID: 22985930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term arsenite exposure induces premature senescence in B cell lymphoma A20 cells.
    Okamura K; Nohara K
    Arch Toxicol; 2016 Apr; 90(4):793-803. PubMed ID: 25787150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of Wnt2 secreted by A-549 cells in paracrine activation of β-catenin in co-cultured mesenchymal stem cells.
    Petrov NS; Popov BV
    Biochemistry (Mosc); 2014 Jun; 79(6):524-30. PubMed ID: 25100010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stabilized beta-catenin functions through TCF/LEF proteins and the Notch/RBP-Jkappa complex to promote proliferation and suppress differentiation of neural precursor cells.
    Shimizu T; Kagawa T; Inoue T; Nonaka A; Takada S; Aburatani H; Taga T
    Mol Cell Biol; 2008 Dec; 28(24):7427-41. PubMed ID: 18852283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lamin A/C Acts as an Essential Factor in Mesenchymal Stem Cell Differentiation Through the Regulation of the Dynamics of the Wnt/β-Catenin Pathway.
    Bermeo S; Vidal C; Zhou H; Duque G
    J Cell Biochem; 2015 Oct; 116(10):2344-53. PubMed ID: 25846419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus core protein modulates pRb2/p130 expression in human hepatocellular carcinoma cell lines through promoter methylation.
    Mileo AM; Mattarocci S; Matarrese P; Anticoli S; Abbruzzese C; Catone S; Sacco R; Paggi MG; Ruggieri A
    J Exp Clin Cancer Res; 2015 Nov; 34():140. PubMed ID: 26576645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.